| Alexium International Group Limited (AJX) ORDINARY FULLY PAID |
Materials |
$22 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 9:15AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
AJX - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cash receipts increased to $1.4 million.
- Financing activities included a $360,000 Line of Credit.
- Net cash used in operating activities was $727,000.
- Manufacturing issues at Dayton Facility affected production.
- Strong sales momentum in mPCM and flame-resistant tech.
- Board remains focused on strategic growth opportunities.
- Negative $154,000 in available funding at quarter's end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$22 |
Quarterly Activities Report/Appendix 4C Cashflow Statement
|
31 Jul 2026 9:14AM |
$0.012 |
$0.011 |
fallen by
8.33%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Algorae Pharmaceuticals Limited expanded its commercial platform to five agreements by partnering with Zydus Lifesciences Ltd and Torrent Pharmaceuticals Limited.
- The Therapeutic Goods Administration (TGA) accepted the Stage 1 registration dossiers for two AlgoraeRx products.
- AlgoraeOS v2 completed the prediction-generation phase, identifying over 478,000 synergy predictions and 6,000 multi-cell-line combinations.
- Algorae partnered with AgenticScale.ai in the Sovereign AI Infrastructure initiative.
- Financial position showed $3.94 million cash at 30 June 2026, with total available funding of $6.94 million.
- Subsequent to the quarter, Algorae secured an NSW Health public hospital supply contract.
- Received positive validation results from a program at Peter Mac and a $49,109 grant from Phenomics Australia.
- Appointed Mr. Troy Valentine to the Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$5 |
Trading Halt
|
31 Jul 2026 9:14AM |
$0.026 |
$0.021 |
fallen by
19.23%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Kuniko Limited (ASX: KNI) requested a trading halt.
- The halt is due to a pending announcement of a proposed capital raise.
- Trading halt effective from 31 July 2026 until 4 August 2026 or announcement release.
- Request made in accordance with ASX Listing Rule 17.1.
- No known reasons for trading halt not to be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Forte Energy Limited (FEL) ORDINARY FULLY PAID |
Energy |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2026 9:14AM |
$0.005 |
$0.006 |
risen by
20%
|
|
FEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued technical review of the Peritas Project in Alaska.
- Secured Mr. Pete Bekkers as New Ventures Advisor.
- Identified high-impact oil exploration opportunities.
- Decided against pursuing additional leases due to high-cost considerations.
- Maintained a cash balance of approximately $1.7 million and no debt.
- Holds 100% interest in 143,368 acres in Alaska and WA-424-P in Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$891 |
Update - Notification of buy-back - FPR
|
31 Jul 2026 9:13AM |
$2.860 |
$4.170 |
risen by
45.80%
|
|
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$356 |
Application for quotation of securities - TBN
|
31 Jul 2026 9:13AM |
$0.220 |
$0.260 |
risen by
18.18%
|
|
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$356 |
Notification regarding unquoted securities - TBN
|
31 Jul 2026 9:13AM |
$0.220 |
$0.260 |
risen by
18.18%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$7 |
Appendix 4C and Quarterly Activities Report - June 2026
|
31 Jul 2026 9:13AM |
$0.013 |
$0.013 |
fallen by
0%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA clearance for MagSense® HER2 Imaging Agent.
- Phase 1b/2 clinical study approval for HER2 positive breast cancer.
- Extension of collaboration with Siemens Healthineers.
- Secured $3.75M in funding commitments for clinical trials.
- Reported cash balance of AU$32K as of 30 June 2026.
- Anticipation of increased operational cash outflows.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$14 |
Security Purchase Plan
|
31 Jul 2026 9:13AM |
$0.012 |
$0.011 |
fallen by
8.33%
|
|
HIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Hawsons Iron Limited to raise $1.5 million through a Share Purchase Plan.
- SPP price set at $0.011 per share, a 15.7% discount.
- Participants receive one free attaching option per share, exercisable at $0.015.
- Funds to finalize studies on hematite by-products and pelletisation.
- Directors of Hawsons Iron intend to participate in the SPP.
- Proceeds to also cover heritage and ecological surveys and corporate costs.
- Additional capital raise due to delays in testing processes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$41 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 9:12AM |
$0.083 |
$0.083 |
fallen by
0%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene Limited reported significant clinical progress with its azer-cel therapy in Phase 1b trials.
- FDA granted Fast Track Designation for azer-cel in additional indications: CLL/SLL and MZL.
- The company completed a capital raise of $16 million through institutional placement and SPP.
- Net cash used in operating activities for the quarter was $9.211 million with R&D expenses totaling $4.261 million.
- Imugene's cash and cash equivalents at the end of June 2026 were $2.510 million.
- Imugene plans to streamline its R&D program and implement cost-cutting measures to manage cash flow.
- The company raised $11.12 million post quarter from a placement with investors.
- Clinical trials for azer-cel were ongoing across ten US and five Australian sites.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Centrepoint Alliance Limited (CAF) ORDINARY FULLY PAID |
Financials |
$71 |
FY26 Results - Investor Webinar
|
31 Jul 2026 9:11AM |
$0.355 |
$0.340 |
fallen by
4.23%
|
|
| EBR Systems Inc (EBR) CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$226 |
Additional Information Regarding Recent Reports
|
31 Jul 2026 9:11AM |
$0.275 |
$0.300 |
risen by
9.09%
|
|
EBR - Price-sensitive ASX Announcement
Full Release
Key Points
- EBR Systems, Inc. is focused on improving cardiac rhythm disease treatment through wireless cardiac pacing.
- The WiSE technology developed by EBR eliminates the need for cardiac pacing leads, reducing complications.
- Two patients developed complications following WiSE system implantation, one resulting in death.
- The incidents were isolated and linked to a known risk; EBR conducted an internal investigation.
- The company's internal assessment found no ongoing concerns, and commercial implants continue.
- WiSE system labeling includes precautions for ultrasound exposure to mitigate risks.
- EBR plans to host an investor webinar to discuss the announcement and preliminary Q2 2026 results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tesoro Gold Ltd (TSO) ORDINARY FULLY PAID |
Materials |
$178 |
Quarterly Activities Report
|
31 Jul 2026 9:11AM |
$0.880 |
$0.990 |
risen by
12.50%
|
|
TSO - Price-sensitive ASX Announcement
Full Release
Key Points
- Tesoro Gold advanced the El Zorro Gold Project in Chile.
- Completion of the infill drilling programme at Ternera Gold Deposit.
- Significant high-grade gold intercepts support resource updates.
- Progress in DFS workstreams across mining, processing, and infrastructure.
- Strategic alliance with STRACON Chile SpA executed.
- Environmental baseline studies are 75% complete.
- DFS and Ternera MRE updates are expected by the end of CY2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Yari Resources Ltd (YAR) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Cashflow Report - June 2026
|
31 Jul 2026 9:11AM |
$0.006 |
$0.005 |
fallen by
25%
|
|
YAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Yari Resources Limited filed a quarterly cash flow report for the period ending June 30, 2026.
- The company reported negative net cash from operating activities amounting to $324,000 for the quarter.
- Cash and cash equivalents at the end of the period were $492,000, down from $816,000 at the beginning of the quarter.
- Significant expenses included exploration and evaluation costs, staff costs, and administration costs.
- The report specifies a one-off employee termination payment impacting net operating cash flows.
- The company expects to continue operations and meet objectives with monitored cash levels and potential fundraising.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Yari Resources Ltd (YAR) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities Report - June 2026
|
31 Jul 2026 9:10AM |
$0.006 |
$0.005 |
fallen by
25%
|
|
YAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Courtney Taylor appointed Managing Director to focus on Queensland coal expansion.
- The company changed its name to Yari Resources Limited to reflect a new strategic direction in the Bowen Basin.
- The Rolleston South Coal Project reported shallow coal intercepts, enhancing the project's potential.
- Yari is advancing partnerships and joint venture opportunities to enhance resource growth.
- Exploration expenditure for the quarter was $0.202 million with a cash position of $0.492 million as of 30 June 2026.
- The Annual General Meeting held on 29 May 2026 approved the name change and other resolutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$33 |
Commercial momentum builds across both platform pillars
|
31 Jul 2026 9:10AM |
$0.066 |
$0.060 |
fallen by
9.09%
|
|
CBL - Price-sensitive ASX Announcement
Full Release
Key Points
- First NextLevel tablets shipped, expected to boost FY27 growth.
- NeuroStrip expanded to 20 organizations across four countries.
- US wholesale channel scaling with Tobii Dynavox and PRC-Saltillo.
- Germany to announce first distribution partner, expanding European presence.
- UK market visit resulted in multiple agreements and further negotiations.
- Positive clinical validation from STROKE LAB in Japan.
- Focused on converting commercial groundwork into revenue.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Power Minerals Limited (PNN) ORDINARY FULLY PAID |
Materials |
$74 |
EXCEPTIONAL HIGH-GRADE RESULTS FROM MAIDEN DRILLING AT MDF
|
31 Jul 2026 9:10AM |
$0.105 |
$0.170 |
risen by
61.90%
|
|
PNN - Price-sensitive ASX Announcement
Full Release
Key Points
- First drill hole MFSR-051 intersects 116m at 4.78% TREO from surface, including 31m at 10.0% TREO and 1.58% MREO from 14m.
- Outstanding MREO of up to 3.36% and TREO of up to 18.12% results in the first hole (MFSR-051) in Power’s maiden drilling program at Morro do Ferro Project.
- Drilling has extended high-grade rare earth mineralisation from previous known 71m to 116m downhole.
- Individual drill core returns up to 181kg/tonne TREO, including 36.6kg/tonne MREO over two metres from 37 metres.
- World class maximum MREO values: 1.0% Pr6O11, 2.55% Nd2O3, 986ppm Dy2O3, and 196ppm Tb4O7 over 2-metre sample intervals.
- MFSR-051 also intersected high-grade critical mineral gallium to end-of-hole, enhancing project economics.
- Drilling planned for approximately 25 drillholes for ~4,000m of diamond core drilling to target depth and expansion of existing high-grade mineralisation.
- Power Minerals Limited is an ASX-listed exploration and development company focused on transforming lithium brine resources in Argentina and developing REE, niobium, and other critical mineral assets in Brazil.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TechGen Metals Ltd (TG1) ORDINARY FULLY PAID |
Materials |
$13 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2026 9:09AM |
$0.027 |
$0.029 |
risen by
7.41%
|
|
TG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Blue Devil project: preparing for drilling with earthworks underway.
- Dalgaranga project: soil sampling identified gold targets; electromagnetic survey completed.
- Mt Boggola project: significant copper intersections from drilling confirmed.
- Capital raised: $2.7 million placement to support exploration activities.
- Cash balance: $2.48 million at the end of the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Powerhouse Ventures Limited (PVL) ORDINARY FULLY PAID |
Financials |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 9:08AM |
$0.140 |
$0.135 |
fallen by
3.57%
|
|
PVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly operating revenue of $1.3 million, up 334% YoY.
- Execution of four corporate advisory mandates across different transaction types.
- Successful restructuring and performance of the Aliwa Alpha Fund with a 35.86% return.
- Strong balance sheet with $6.27 million in liquid and ASX-listed assets.
- Expansion of global co-managed Technology Fund.
- Continued momentum and optimism in investment and growth strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Saturn Metals Limited (STN) ORDINARY FULLY PAID |
Materials |
$269 |
Quarterly Activities and Cashflow Report
|
31 Jul 2026 9:07AM |
$0.410 |
$0.440 |
risen by
7.32%
|
|
STN - Price-sensitive ASX Announcement
Full Release
Key Points
- Saturn Metals Limited achieved a significant increase in the Apollo Hill Gold Project's Mineral Resource, now totaling 2.83 million ounces.
- A Native Title Mining Agreement was executed, facilitating the project's development progress.
- Significant drill results indicate potential for further resource growth and development at Apollo Hill.
- Saturn completed a large-scale ground gravity survey to aid exploration targeting.
- The company divested non-core assets in NSW to focus on Apollo Hill, while retaining exposure to future exploration through Xpedra Resources.
- Saturn appointed experienced mining executive Warren Hallam as a Non-Executive Director.
- The company's cash position at the end of the quarter stood at $40.4 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Yugo Metals Limited (YUG) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2026 9:06AM |
$0.048 |
$0.052 |
risen by
8.33%
|
|
YUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Yugo Metals Limited completed a maiden drill campaign at the Erak Prospect with promising gold results.
- Five drillholes were drilled at Erak with ongoing operations, and best results included 8m at 1.2 g/t gold.
- Post-quarter plans include drilling at the Cajnice Project to explore gold-silver-lead mineralisation.
- A $5.0M placement was completed to fund drilling across three projects: Sinjakovo, Sockovac, and Cajnice.
- Cash flow report indicates a net cash outflow from operations but a positive net cash inflow from financing activities.
- The company had a cash balance of approximately $6.3 million at the end of the quarter.
- Exploration licenses are held in Bosnia and Herzegovina for Sinjakovo, Sockovac, and Cajnice projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tetragon Energy Limited (TET) ORDINARY FULLY PAID |
Energy |
$10 |
Quarterly Activities and Cashflow Report
|
31 Jul 2026 9:06AM |
$0.225 |
$0.240 |
risen by
6.67%
|
|
TET - Price-sensitive ASX Announcement
Full Release
Key Points
- Tetragon Energy listed on ASX on 9 July 2026 after raising $4 million in an IPO.
- Tetragon holds interests in three Philippine permits: SC-80, SC-81, and SC-82.
- Company plans to focus on advancing its Philippine assets, with potential expansions being evaluated.
- As of 30 June 2026, Tetragon had cash reserves of $716,000.
- The company's exploration expenditure for the quarter was $282,000.
- Shares issued and market capitalization upon listing were 39,700,408 shares and $7.9 million respectively.
- Tetragon's quarterly reports detail contingent and prospective resources in the Philippines.
- Key projects include SC-80 and SC-81 in the Sandakan Basin and SC-82 in the Cagayan Basin.
- The company is focused on reprocessing seismic data and evaluating new acquisition opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blue Energy Limited (BLU) ORDINARY FULLY PAID |
Energy |
$12 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2026 9:05AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
BLU - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities: $340,000.
- Net cash used in investing activities: $248,000.
- Net cash from financing activities: $5,479,000.
- Exploration permits in Bowen and Surat Basins, Queensland.
- Involvement in Wiso Basin projects, Northern Territory.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IODM Limited (IOD) ORDINARY FULLY PAID |
Information Technology |
$60 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 9:05AM |
$0.095 |
$0.095 |
fallen by
0%
|
|
IOD - Price-sensitive ASX Announcement
Full Release
Key Points
- Q4 FY26 cash receipts of A$803k, a 14% increase from the previous corresponding period.
- FY26 total cash receipts were A$3.431M, up 29% from the previous period.
- Significant growth in the UK Education segment with cash receipts of A$590k, a 15.9% increase.
- Renegotiated terms with Convera UK, removing exclusivity and increasing revenue share to 30%.
- Progress in the USA with a platform agreement for over 283 universities.
- Development of new features for education sector, including an E-Commerce store and digital credit scoring.
- Net cash used in operating activities was A$842k for the quarter.
- Reports an expected R&D rebate for FY26 exceeding A$500k.
- Net cash from financing activities totaled A$954k with borrowings and repayment activities outlined.
- IODM operates globally with a focus on automating accounts receivable processes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$115 |
Notice of General Meeting/Proxy Form
|
31 Jul 2026 9:04AM |
$0.375 |
$0.375 |
fallen by
0%
|
|
Call 1300 880 160
Start a chat
Schedule a call
